DexCom, Inc. ( DXCM) recently revealed the U.S. Food and Drug Administration (FDA) approval for a new algorithm designed for its G4 PLATINUM Continuous Glucose Monitoring (CGM) system. Following the ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the U.S. Food and Drug Administration (FDA) has approved new software for ...

This latest software enhancement to DexCom G4 Platinum will make the performance level of blood glucose monitoring comparable to finger stick meters, the traditional standard-of-care for the same.

Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. launch of the latest generation of its continuous glucose monitor, the G7, after the FDA raised questions about the device’s ...

(Corrects to identify the issue is with the Dexcom Follow monitoring service, not the monitor itself) NEW YORK, Dec 1 (Reuters) - Dexcom Inc, which makes continuous glucose monitoring systems that can ...

NEW YORK, Dec 1 (Reuters) - Dexcom Inc, which makes continuous glucose monitoring systems that can be used by adults to track sugar levels in children with diabetes, said on its website Sunday that ...

DexCom DXCM recently announced that it has received FDA clearance for its CGM-integrated basal insulin dosing optimizer, Dexcom Smart Basal, for use by adults with Type 2 diabetes on glargine U-100 ...

DexCom's not just a diabetes company anymore. They're at the forefront of wearable health tech, blurring the lines between medicine and lifestyle. DexCom might not be the flashiest stock, but their ...

Chicago, IL – April 21, 2023 – Today, Zacks Investment Ideas feature highlights Nvidia NVDA, First Solar FSLR, Intuitive Surgical ISRG, Dexcom DXCM and Asure Software ASUR. Thus far this year, ...

DexCom, incorporated in Delaware and headquartered in San Diego, California, designs, manufactures, and markets continuous glucose monitoring (CGM) systems to help individuals with types 1 and 2 ...